Search - tctmd.com

Displaying 41 - 60 of 621

Sort: Relevancy | Date

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

News Conference News NY Valves 2024

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Michael O'Riordan

June 06, 2024

News Conference News NY Valves 2024

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Todd Neale

June 06, 2024

Presentation NY Valves 2024

The Costs of Low-Risk TAVR Implant and All-Cause, Long-Term Follow Up Care in the Medicare Fee-For-Service Population

Presenter: Kael Wherry

June 06, 2024

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News ACC 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Yael L. Maxwell

April 05, 2024

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

News Conference News STS 2024

SAVR After Failed TAVI on the Rise, With High Mortality

Yael L. Maxwell

February 05, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

Podcast Taking It To Heart

Episode 18: Low-risk TAVR Trials - Insights from TCT 2023 Part 1

January 04, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Advertisement

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

National Data Point to Soaring TAVI Rates in Patients Under 65

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Long-term Mortality After TAVI Lower With DOACs vs VKAs

The Costs of Low-Risk TAVR Implant and All-Cause, Long-Term Follow Up Care in the Medicare Fee-For-Service Population

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

SAVR After Failed TAVI on the Rise, With High Mortality

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Episode 18: Low-risk TAVR Trials - Insights from TCT 2023 Part 1

Top Structural Heart News of 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

TCTMD’s Top 10 Most Popular Stories for October 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content